PARTIAL-ONSET SEIZURES
Clinical trials for PARTIAL-ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new PARTIAL-ONSET SEIZURES trials appear
Sign up with your email to follow new studies for PARTIAL-ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug shows promise for kids in early trial
Disease control OngoingThis study tests whether adding perampanel (Fycompa) to current epilepsy medications can reduce seizures in children aged 1 month to 18 years. About 100 children with specific epilepsy syndromes or partial-onset seizures will receive the drug. The main goal is to see if at least …
Matched conditions: PARTIAL-ONSET SEIZURES
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Bridge program keeps seizure drug available for eligible patients
Disease control NO_LONGER_AVAILABLEThis program provides continued access to the seizure medication perampanel (Fycompa) for people who completed certain earlier studies and are still benefiting from the drug. It runs until the drug is commercially available in their country or no participants remain. Only those a…
Matched conditions: PARTIAL-ONSET SEIZURES
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC